BRAIN Biotech AG
SWB:BNN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BRAIN Biotech AG
SWB:BNN
|
DE |
|
D
|
Deckers Outdoor Corp
XBER:DO2
|
US |
|
L E Lundbergforetagen AB (publ)
OTC:LBGUF
|
SE |
|
W
|
Wolters Kluwer NV
F:WOSB
|
NL |
|
T
|
TotalEnergies SE
SWB:TOTB
|
FR |
|
Equinor ASA
OSE:EQNR
|
NO |
|
C
|
Ctac NV
AEX:CTAC
|
NL |
|
I
|
Interactive Brokers Group Inc
SWB:KY6
|
US |
|
Yara International ASA
LSE:0O7D
|
NO |
|
D
|
Delta Air Lines Inc
LSE:0QZ4
|
US |
|
Euroseas Ltd
NASDAQ:ESEA
|
GR |
Wall St Price Targets
BNN Price Targets Summary
BRAIN Biotech AG
According to Wall Street analysts, the average 1-year price target for BNN is 5.55 EUR with a low forecast of 5 EUR and a high forecast of 6.75 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BNN's stock price target?
Price Target
5.55
EUR
According to Wall Street analysts, the average 1-year price target for BNN is 5.55 EUR with a low forecast of 5 EUR and a high forecast of 6.75 EUR.
What is the Revenue forecast for BRAIN Biotech AG?
Projected CAGR
10%
Over the last 12 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for BRAIN Biotech AG?
Projected CAGR
9%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 9%.
